ArticleParasitology research2024
Therapeutic effect of GP543 strain of Bacillus thuringiensis against Amblyomma cajennense ticks in vitro and in naturally infested cattle.
Article in Parasitology research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The current study was focused on evaluating the in vitro effect of the spore-crystal complex of GP543 Bacillus thuringiensis strain on the viability of Amblyomma cajennense, and the in vivo reduction of the parasite load of this ectoparasite on naturally infested cattle. In vitro, 30 adult ticks were treated with 1.2 mg/ml of B. thuringiensis GP543 strain spore-crystal complex in 10 µl/ml of AGREX F® surfactant and 20% glycerin, subjected to the immersion test to assess their viability every 1.5 h up to 6 h and finally at 12 h post-immersion. GP543 was compared to 125 µg/ml of the commercial drug BOMBARD® (amitraz). In vivo, the same concentrations were tested on naturally infested Swiss-Zebu heifers in grazing conditions. Treatments were applied on the perineal region in an area of 30 × 15 cm on days 0 and 7, and the parasite load was determined on days 0, 3, 7, 9, 14, and 21. In vitro, GP543 decreased the viability rate a 96.6% at 12 h post-immersion, while the commercial drug induced a 100% decrease of viability. On heifers, the parasite load decreased after 21 days in the group treated with GP543 in a similar way to the group treated with amitraz. Considering the above, GP543 strain of B. thuringiensis is proposed as a candidate for the control of Amblyomma cajennense.
Indexed as
Identifiers
39680186What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.